OMNIAB, INC. Amortization of Intangible Assets
OMNIAB, INC. (OABI) reported Amortization of Intangible Assets of $3.05 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AmortizationOfIntangibleAssets · last filed 2026-08-06
- OMNIAB, INC. amortization of intangible assets for the quarter ending 2026-06-30 was $3.05M, a 5.42% decline year-over-year.
- OMNIAB, INC. amortization of intangible assets for the quarter ending 2026-03-31 was $6.03M, a 86.74% increase year-over-year.
- OMNIAB, INC. amortization of intangible assets for the quarter ending 2025-12-31 was $3.23M, a 46.72% decline year-over-year.
- OMNIAB, INC. amortization of intangible assets for the quarter ending 2025-09-30 was $3.23M, a 4.86% decline year-over-year.
- OMNIAB, INC. amortization of intangible assets for fiscal 2025 was $12.91M, a 25.82% decline from fiscal 2024.
- OMNIAB, INC. amortization of intangible assets for fiscal 2024 was $17.41M, a 28.43% increase from fiscal 2023.
- OMNIAB, INC. amortization of intangible assets for fiscal 2023 was $13.55M, a 3.86% increase from fiscal 2022.
- OMNIAB, INC. amortization of intangible assets for fiscal 2022 was $13.05M, a 0.63% increase from fiscal 2021.
| Period end | Amortization of Intangible Assets 3 month | Amortization of Intangible Assets 6 month | Amortization of Intangible Assets 9 month | Amortization of Intangible Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | $3.05M 10-Q · filed 2026-08-06 | $9.08M 10-Q · filed 2026-08-06 | $12.31M derived: sum of 3 quarters · filed 2026-08-06 | $15.54M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $6.03M 10-Q · filed 2026-05-07 | $9.26M derived: sum of 2 quarters · filed 2026-05-07 | $12.48M derived: sum of 3 quarters · filed 2026-05-07 | $15.71M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $3.23M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | $6.46M derived: sum of 2 quarters · filed 2026-03-04 | $9.68M derived: sum of 3 quarters · filed 2026-08-06 | $12.91M 10-K · filed 2026-03-04 |
| 2025-09-30 | $3.23M 10-Q · filed 2025-11-04 | $6.46M derived: sum of 2 quarters · filed 2026-08-06 | $9.68M 10-Q · filed 2025-11-04 | $15.74M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $3.23M 10-Q · filed 2026-08-06 | $6.46M 10-Q · filed 2026-08-06 | $12.52M derived: sum of 3 quarters · filed 2026-08-06 | $15.91M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $3.23M 10-Q · filed 2026-05-07 | $9.29M derived: sum of 2 quarters · filed 2026-05-07 | $12.68M derived: sum of 3 quarters · filed 2026-05-07 | $17.22M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $6.06M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | $9.45M derived: sum of 2 quarters · filed 2026-03-04 | $13.99M derived: sum of 3 quarters · filed 2026-03-04 | $17.41M 10-K · filed 2026-03-04 |
| 2024-09-30 | $3.39M 10-Q · filed 2025-11-04 | $7.94M derived: sum of 2 quarters · filed 2025-11-04 | $11.35M 10-Q · filed 2025-11-04 | $14.76M derived: sum of 4 quarters · filed 2025-11-04 |
| 2024-06-30 | $4.54M 10-Q · filed 2025-08-06 | $7.96M 10-Q · filed 2025-08-06 | $11.36M derived: sum of 3 quarters · filed 2025-08-06 | $14.76M derived: sum of 4 quarters · filed 2025-08-06 |
| 2024-03-31 | $3.41M 10-Q · filed 2025-05-08 | $6.82M derived: sum of 2 quarters · filed 2025-05-08 | $10.22M derived: sum of 3 quarters · filed 2025-05-08 | $13.60M derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | $3.41M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-18 | $6.80M derived: sum of 2 quarters · filed 2025-03-18 | $10.19M derived: sum of 3 quarters · filed 2025-03-18 | $13.55M 10-K · filed 2025-03-18 |
| 2023-09-30 | $3.40M 10-Q · filed 2024-11-12 | $6.78M derived: sum of 2 quarters · filed 2024-11-12 | $10.15M 10-Q · filed 2024-11-12 | $13.42M derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $3.38M 10-Q · filed 2024-08-08 | $6.75M 10-Q · filed 2024-08-08 | $10.03M derived: sum of 3 quarters · filed 2024-08-08 | $13.28M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $3.37M 10-Q · filed 2024-05-09 | $6.64M derived: sum of 2 quarters · filed 2024-05-09 | $9.90M derived: sum of 3 quarters · filed 2024-05-09 | $13.01M derived: sum of 4 quarters · filed 2024-05-09 |
| 2022-12-31 | $3.28M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-25 | $6.53M derived: sum of 2 quarters · filed 2024-03-25 | $9.64M derived: sum of 3 quarters · filed 2024-03-25 | $13.05M 10-K · filed 2024-03-25 |
| 2022-09-30 | $3.26M 10-Q · filed 2023-11-09 | $6.37M derived: sum of 2 quarters · filed 2023-11-09 | $9.77M 10-Q · filed 2023-11-09 | |
| 2022-06-30 | $3.11M 10-Q · filed 2023-08-10 | $6.52M 10-Q · filed 2023-08-10 | ||
| 2022-03-31 | $3.40M 10-Q · filed 2023-05-11 | |||
| 2021-12-31 | $12.97M 10-K · filed 2023-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |